APAC CIOOutlook
About UsConferencePartner With Us
  • Technologies
    • Blockchain
      Data Intelligence and Management
      Digital Transformation
      FinTech
      Generative and Agentic AI
      Low Code No Code
      Mobile Application
      Networking
      Robotics
      Storage
      Wireless
  • Industries
    • Automotive
      Aviation
      Banking
      Construction
      E-Commerce
      Food and Beverages
      Healthcare
      Insurance
      Logistics
      Manufacturing
      Retail
      Supply Chain
      Travel and Hospitality
  • Platforms
    • Microsoft
      Salesforce
      SAP
  • Strategic Solutions
    • Business Intelligence
      Contact Center
      Corporate Finance
      CRM
      Cyber Security
      Data Center
      Enterprise Asset Management
      Enterprise Performance Management
      IT Infrastructure and Services
      Managed Services
      Procurement
      Unified Communication
      Workflow
  • Home
  • CXO Insights
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Whitepapers
  • CXO Awards
#

Apac CIOOutlook Weekly Brief

×

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by the Construction Tech Review Advisory Board.

NTT Data Services

Adam Nelson, COO, Life Sciences

Precision Medicine and Real-World Data: Don't Let Shiny Objects Distract From the Core Issue of Integration

Adam Nelson

Adam Nelson

One of the challenges life sciences organizations face in creating precisely targeted therapies is the need for greater engagement with patients and the ongoing need to collect detailed and accurate real-world patient data. For research and development, patient data is critical for monitoring across the lifecycle of the drug/therapy and demonstrating efficacy for value-based contracts with payers, as is supporting the patient to ensure adherence and continuity of therapy. Additionally, real-world evidence collection enables partnerships between payers, providers, and pharmaceuticals, with a supportive and integrated robust supply chain and scientific health tech infrastructure.

Two transformational waves in the quest for better and more insightful information and deeper engagement are data from the Internet of Things (IoT) and digital technology. The number of connected devices that could be useful in life sciences is expanding rapidly, and the data from those devices could revolutionize many aspects of drug development and marketing, accelerating research and development while also lowering the costs of gathering accurate patient data. And there’s some interesting and innovative IoT technology to use.

But for pharmas and other life sciences organizations, the challenge in adopting IoT devices is not necessarily with having things that work for the objective and work easily for the participant, but in the data the devices collect. The key issue isn’t the sensors or devices, but rather how to effectively integrate the resultant data in a way that helps meets business goals.

The key issue is creating architecture to ensure the usability of the data and business processes to make sure you are collecting the data you really need and that you are using the data effectively. Finding the right devices, given differences in protocols during trial versus post-care therapy or rehabilitation is a challenge, yet one, manufacturers should solve as they bring products to market.

Given the complexity of integrating real-world patient data, the first step is to identify and clearly define goals. Do you need real-world data for patient stratification? Or do you need to prove efficacy? The two are similar yet have very different requirements for sharing, presenting, and analyzing. With a well-defined goal, you can evaluate your current capabilities and the technical requirements for integrating the data.

The Key Issue Is How To Effectively Integrate Data In A Way That Helps Meets Business Goals


And you can set up the right processes to ensure you use the data efficiently while maintaining regulatory compliance when and where required.

Lack of standards can rapidly lead to chaos

Another difficulty with IoT is the lack of standards. There are many different software platforms and systems being brought to market and most are specialized, solving a few issues in the ecosystem. They are as focused in their intent as precision medicine. The advantage to this is they solve the issue really well, but the challenge is the life sciences buyer ends up with a multitude of specialty systems, all requiring integration.

The SaaS and PaaS models individually require cost-effective budget for support, maintenance, and upgrade. Yet capturing and integrating all the data between the systems requires an entirely new layer, one which must be architected, developed, and maintained.

Wireless enabled devices, such as scales and blood pressure monitors, which require action by the patient to acquire data have been the quickest products to market, because they take an existing device and add digital communication capabilities. In time, wearables will probably be the product family that transforms clinical trials and efficacy monitoring most significantly. With the ability to capture information without the participant even realizing it is being done, you can expect more accurate information and more adherence to trial parameters, which leads to the ability to learn faster, make conclusions quicker, and lower the overall cost of drug discovery and product launch.

Real-world evidence to support the value of therapies

For patient medication adherence, real-world evidence is important to ensure drug efficacy and also for showing payers that medication outcomes are performing as trialed. Increasingly, payers are seeking contracts that set goals for efficacy, and patient adherence becomes critical to financial performance. Real-time patient feedback can help alert caregivers to adherence issues, allowing them to quickly offer support and keep the patient working toward better outcomes.

And how better to collect real-world evidence than through wearables and digital technology, including smart phones, smart homes and connected vehicles and offices?

This, however, comes at a price – consumer expectations applied to scientific and business use. We purchase a new smart phone and expect it to simply work. The same now holds true of a thermostat or connected car device and app that controls your teenager’s driving patterns. It is in this expectation of simplicity that the life sciences industry will see distraction.

The expectation and the distraction will be to collect data from wearables, mobile, and digital enabled devices in real-time, and once collected, present that data in a visual format that enables business insights and decision making in real time. However, the insights are derived from an ecosystem, not a set of devices or a specialty platform, thus an integrated view is required. Because our expectations for how digital technology should work have been set by our experience with consumer digital products, users will expect that same level of speed and simplicity in the more complex world of business and science.

To avoid the distraction and take full advantage of the enormous value IoT and digital technology offers, it makes sense to find a really good systems integration partner. The integration team can then focus on meeting the speed and simplicity expectations of users and creating a solid, future-looking foundation. That will leave you free to focus on the data and how to use it. The last thing you want to do is to get so bogged down in the details that you miss the opportunity that IoT and digital technology offers.

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping construction technology and innovation. Participation is by invitation only. It features leaders who are not merely observing technological change, but actively contributing to it through digital transformation and execution-driven insights.
EDITOR'S CHOICE
  • Willis Towers Watson

    ISS Facility Services Australia & New Zealand

    The Right Technology And Reliable Partners; The Business Next Frontier

    Luke O'Brien, CIO

  • Willis Towers Watson

    BPAY Group

    Building BPAY Group's New Digital Foundation

    Angela Donohoe, Chief Information Officer

  • Willis Towers Watson

    Bvn Architecture

    How Have Recent Advancements in Big Data Been Impacting Businesses?

    Marc Solomon, CIO

  • Willis Towers Watson

    Tassal Operations

    BI & Analytics in Aquaculture

    Matthew Leary, CIO

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

APAC CIOOutlook
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@apacciooutlook.com
  • sales@apacciooutlook.com
  • marketing@apacciooutlook.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 APAC CIOOutlook. All rights reserved. Headquarteblue in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://pharma.apacciooutlook.com/leadership-perspective/precision-medicine-and-realworld-data-dont-let-shiny-objects-distract-from-the-core-issue-of-integration-nwid-4616.html